ATE357439T1 - Pyrazol-derivative als inhibitoren der reversen hiv-transkriptase - Google Patents

Pyrazol-derivative als inhibitoren der reversen hiv-transkriptase

Info

Publication number
ATE357439T1
ATE357439T1 AT02758207T AT02758207T ATE357439T1 AT E357439 T1 ATE357439 T1 AT E357439T1 AT 02758207 T AT02758207 T AT 02758207T AT 02758207 T AT02758207 T AT 02758207T AT E357439 T1 ATE357439 T1 AT E357439T1
Authority
AT
Austria
Prior art keywords
inhibitors
pyrazole derivatives
compounds
reverse hiv
hiv transcriptase
Prior art date
Application number
AT02758207T
Other languages
English (en)
Inventor
Brian William Dymock
Adrian Liam Gill
Philip Stephen Jones
Kevin Edward Burdon Parkes
Martin John Parratt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE357439T1 publication Critical patent/ATE357439T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT02758207T 2001-06-04 2002-05-29 Pyrazol-derivative als inhibitoren der reversen hiv-transkriptase ATE357439T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113524.3A GB0113524D0 (en) 2001-06-04 2001-06-04 Pyrazole derivatives

Publications (1)

Publication Number Publication Date
ATE357439T1 true ATE357439T1 (de) 2007-04-15

Family

ID=9915841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02758207T ATE357439T1 (de) 2001-06-04 2002-05-29 Pyrazol-derivative als inhibitoren der reversen hiv-transkriptase

Country Status (17)

Country Link
US (1) US6538015B1 (de)
EP (1) EP1401826B1 (de)
JP (1) JP4088249B2 (de)
KR (1) KR100627532B1 (de)
CN (1) CN1249052C (de)
AT (1) ATE357439T1 (de)
AU (1) AU2002325221B2 (de)
BR (1) BR0210158A (de)
CA (1) CA2448058C (de)
DE (1) DE60219009T2 (de)
DK (1) DK1401826T3 (de)
ES (1) ES2282446T3 (de)
GB (1) GB0113524D0 (de)
MX (1) MXPA03011199A (de)
PT (1) PT1401826E (de)
WO (1) WO2002100853A1 (de)
ZA (1) ZA200308781B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
JP4993407B2 (ja) 2004-08-04 2012-08-08 大正製薬株式会社 トリアゾール誘導体
CA2592909A1 (en) * 2005-01-06 2006-07-13 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
PL1988083T3 (pl) 2006-02-03 2014-08-29 Taisho Pharmaceutical Co Ltd Pochodna triazolowa
RU2395499C2 (ru) 2006-02-06 2010-07-27 Тайсо Фармасьютикал Ко., Лтд. Ингибитор связывания сфингозин-1-фосфата
DE602007013573D1 (de) 2006-08-16 2011-05-12 Hoffmann La Roche Nicht-nukleosidische reverse-transkriptase-hemmer
WO2009000663A1 (en) 2007-06-22 2008-12-31 F. Hoffmann-La Roche Ag Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors
ATE554070T1 (de) 2007-08-01 2012-05-15 Taisho Pharmaceutical Co Ltd Hemmer der s1p1-bindung
AU2008340422B2 (en) 2007-12-21 2014-06-19 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
EP2295038B1 (de) * 2009-09-11 2013-05-29 AiCuris GmbH & Co. KG Festdispergierung mit einem Anti-HIV-Wirkstoff
WO2011144549A1 (en) * 2010-05-20 2011-11-24 Bayer Cropscience Ag Method for manufacturing 1 - alkyl - 3 - difluormethyl - 5 - hydroxypyrazoles
ES2565193T3 (es) 2010-07-15 2016-04-01 Sumitomo Dainippon Pharma Co., Ltd. Compuesto de pirazol
US9695127B2 (en) 2012-11-08 2017-07-04 University of Pittsburgh—of the Commonwealth System of Higher Education Compounds for treating HIV and methods for using the compounds
US9925190B2 (en) 2015-02-16 2018-03-27 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecules targeting HIV-1 Nef

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015060A1 (fr) 1992-01-22 1993-08-05 Nissan Chemical Industries, Ltd. Derive de pyrazole substitue et bactericide agrohorticole
US6005109A (en) 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
BR9509024A (pt) 1994-09-26 1997-09-30 Shionogi & Co Derivados de imidazol
US5698495A (en) 1995-11-15 1997-12-16 Zeneca Limited Herbicidal substituted pyrazole compounds
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
GB0024795D0 (en) 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases

Also Published As

Publication number Publication date
MXPA03011199A (es) 2004-02-26
EP1401826B1 (de) 2007-03-21
DE60219009D1 (de) 2007-05-03
JP4088249B2 (ja) 2008-05-21
DK1401826T3 (da) 2007-07-30
CN1527829A (zh) 2004-09-08
US6538015B1 (en) 2003-03-25
CN1249052C (zh) 2006-04-05
KR100627532B1 (ko) 2006-09-21
CA2448058A1 (en) 2002-12-19
JP2004532276A (ja) 2004-10-21
DE60219009T2 (de) 2007-12-13
AU2002325221B2 (en) 2008-07-31
CA2448058C (en) 2008-12-23
BR0210158A (pt) 2004-06-08
WO2002100853A1 (en) 2002-12-19
GB0113524D0 (en) 2001-07-25
KR20040003050A (ko) 2004-01-07
EP1401826A1 (de) 2004-03-31
PT1401826E (pt) 2007-06-19
ES2282446T3 (es) 2007-10-16
ZA200308781B (en) 2005-02-11

Similar Documents

Publication Publication Date Title
YU27203A (sh) Pirazol derivati za tretiranje virusnih oboljenja
DE60219009D1 (de) Pyrazol-derivative als inhibitoren der reversen hiv-transkriptase
EA200300943A1 (ru) Производные пиразола для лечения инфекции вируса иммунодефицита человека (вич)
CY1106207T1 (el) Αντιιικα παραγωγα νουκλεοζιτων
WO2004071426A3 (en) Compounds for the treatment of viral infection
BRPI0511982A (pt) compostos antiviróticos heterocìclicos
DE60318891D1 (de) Cyclopropylverbindungen als ccr5 antagonisten
MXPA05010210A (es) Inhibidores no nucleosidos de transcriptasa inversa para tratar las enfermedades mediadas por el virus de la inmunodeficiencia humana (vih).
HUP0303082A2 (hu) Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk
WO2002079186A3 (en) Aminopiperidine derivatives as modulators of chemokine receptor activity
MXPA02012409A (es) Derivados de pirrol para tratamiento del sida.
ATE384714T1 (de) Pyrazolderivate
EA202192111A1 (ru) Новые тритерпеновые производные в качестве ингибиторов вич
DE60319254D1 (de) Pyrazolamide zur behandlung von hiv-infektionen
DK1404656T3 (da) Derivater af benzimidazol til behandling af sygdomme forbundet med en aktivering af mikroglia, såsom inflammatoriske, allergiske, inficerende eller autoimmune sygdomme
HUP0203161A2 (hu) Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
EA200500287A1 (ru) Производные 4-(3, 5-дицианофенокси)пиразола для применения в качестве модуляторов обратной транскриптазы в лечении, в числе прочего, вич-инфекции
BR0115476A (pt) Derivados de imidazolona para o tratamento de doenças virais
ATE374775T1 (de) Inhibitoren des hiv-integrase-enzyms
AU2003264940A1 (en) Pyrazole derivatives and their use as therapeutic agents for hiv mediated diseases
AP1846A (en) Pyrazole Derivatives.
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )
WO2005028442A3 (en) 2-pyridinone derivatives, having hiv inhibiting properties

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1401826

Country of ref document: EP

REN Ceased due to non-payment of the annual fee